National Health Investors Stock Price Target and Analyst Ratings (NYSE:NHI)

Analyst Price Target for NHI

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$64.29

▼ -3.39% Downside Potential

This price target is based on 8 analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $64.29, with a high forecast of $94.00 and a low forecast of $40.00. The average price target represents a -3.39% upside from the last price of $66.54.

Hold

The current consensus among 8 investment analysts is to hold stock in National Health Investors. This rating has held steady since February 2020, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
0 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

7/30/2019

0 strong buy ratings
0 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

10/28/2019

0 strong buy ratings
0 buy ratings
1 hold ratings
2 sell ratings

Ratings as of

1/26/2020

0 strong buy ratings
0 buy ratings
4 hold ratings
2 sell ratings

Ratings as of

4/25/2020

0 strong buy ratings
0 buy ratings
5 hold ratings
2 sell ratings

Ratings as of

7/24/2020

0 strong buy ratings
0 buy ratings
6 hold ratings
2 sell ratings

Ratings as of

10/22/2020

0 strong buy ratings
0 buy ratings
6 hold ratings
2 sell ratings

Ratings as of

12/21/2020

0 strong buy ratings
0 buy ratings
6 hold ratings
2 sell ratings

Ratings as of

1/20/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
1/13/2021	Mizuho	Downgrade	Neutral ➝ Underperform	$56.00 ➝ $55.00	Medium	i
1/7/2021	BMO Capital Markets	Downgrade	Market Perform ➝ Underperform	$68.00	Low	i
12/14/2020	KeyCorp	Upgrade	Underweight ➝ Sector Weight		Medium	i
12/2/2020	Berenberg Bank	Downgrade	Buy ➝ Hold		Low	i
9/1/2020	Stifel Nicolaus	Reiterated Rating	Hold	$63.00	High	i
6/24/2020	SunTrust Banks	Boost Price Target	Hold	$61.00 ➝ $64.00	Low	i
6/17/2020	Wells Fargo & Company	Boost Price Target	Equal Weight	$54.00 ➝ $66.00	High	i
6/8/2020	JMP Securities	Initiated Coverage	Market Perform		High	i
5/22/2020	Mizuho	Downgrade	Buy ➝ Neutral	$60.00 ➝ $55.00	Medium	i
5/14/2020	KeyCorp	Lower Price Target	Underweight	$43.00 ➝ $40.00	High	i
4/23/2020	SunTrust Banks	Lower Price Target	Hold	$77.00 ➝ $61.00	Low	i
4/21/2020	KeyCorp	Lower Price Target	Underweight	$65.00 ➝ $43.00	Medium	i
3/26/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$82.00 ➝ $51.00	High	i
2/5/2020	Berenberg Bank	Initiated Coverage	Buy	$94.00	Medium	i
1/7/2020	BMO Capital Markets	Upgrade	Underperform ➝ Market Perform	$74.00 ➝ $82.00	Low	i
12/20/2019	Mizuho	Reiterated Rating	Buy	$95.00	High	i
2/20/2019	SunTrust Banks	Boost Price Target	Hold ➝ Neutral	$85.00	High	i
2/20/2019	BMO Capital Markets	Downgrade	Market Perform ➝ Underperform	$78.00	Medium	i
12/20/2018	KeyCorp	Set Price Target	Sell	$65.00	High	i Rating by Craig Mailman at KeyCorp
11/8/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$80.00	Low	i Rating by J. France at Cantor Fitzgerald
8/28/2018	Wells Fargo & Company	Reiterated Rating	Hold		Low	i Rating by Todd Stender at Wells Fargo & Company
8/8/2018	Cantor Fitzgerald	Boost Price Target	Neutral ➝ Neutral	$75.00 ➝ $80.00	Low	i Rating by J. France at Cantor Fitzgerald
8/8/2018	SunTrust Banks	Reiterated Rating	Hold	$79.00	Medium	i Rating by Eric Fleming at SunTrust Banks, Inc.
8/7/2018	Stifel Nicolaus	Set Price Target	Buy	$83.00	Medium	i Rating by Chad Vanacore at Stifel Nicolaus
5/31/2018	Wells Fargo & Company	Set Price Target	Market Perform ➝ Market Perform	$68.00 ➝ $75.00	Low	i
5/16/2018	Cantor Fitzgerald	Reiterated Rating	Neutral		Medium	i Rating by J. France at Cantor Fitzgerald
5/11/2018	Capital One Financial	Upgrade	Equal Weight ➝ Overweight		Low	i Rating by D. Bernstein at Capital One Financial Co.
5/8/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$75.00	Medium	i
4/17/2018	KeyCorp	Lower Price Target	Underweight ➝ Sell	$70.00 ➝ $60.00	Low	i
3/26/2018	BMO Capital Markets	Set Price Target	Hold	$70.00	Low	i Rating by John Kim at BMO Capital Markets
2/26/2018	Mizuho	Reiterated Rating	Hold	$70.00	High	i
2/17/2018	Stifel Nicolaus	Set Price Target	Buy	$76.00	Medium	i Rating by Chad Vanacore at Stifel Nicolaus
2/17/2018	SunTrust Banks	Set Price Target	Hold	$70.00	Medium	i Rating by Eric Fleming at SunTrust Banks, Inc.
2/16/2018	Hilliard Lyons	Upgrade	Neutral ➝ Buy		Low	i
2/16/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$85.00	High	i
1/22/2018	SunTrust Banks	Set Price Target	Hold	$75.00	Low	i Rating by Eric Fleming at SunTrust Banks, Inc.
1/17/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$85.00	Low	i
1/12/2018	Stephens	Set Price Target	Buy	$79.00	High	i Rating by Dana Hambly at Stephens
12/19/2017	KeyCorp	Reiterated Rating	Sector Weight ➝ Underweight		Medium	i
11/24/2017	KeyCorp	Reiterated Rating	Hold		N/A	i
10/23/2017	Capital One Financial	Initiated Coverage	Equal Weight		N/A	i Rating by D. Bernstein at Capital One Financial Co.
10/18/2017	BMO Capital Markets	Reiterated Rating	Hold	$80.00	N/A	i
10/10/2017	SunTrust Banks	Initiated Coverage	Hold	$80.00	N/A	i
10/4/2017	Mizuho	Reiterated Rating	Hold	$82.00	Low	i
10/4/2017	Stifel Nicolaus	Reiterated Rating	Buy	$82.00	Low	i
9/17/2017	KeyCorp	Reiterated Rating	Hold		Low	i
6/28/2017	Mizuho	Reiterated Rating	Neutral		Low	i
6/21/2017	Stifel Nicolaus	Boost Price Target	Buy	$80.00 ➝ $82.00	Low	i
5/22/2017	Bank of America	Downgrade	Neutral ➝ Underperform	$76.00	Low	i
2/21/2017	Cantor Fitzgerald	Reiterated Rating	Neutral	$75.00	N/A	i Rating by Joseph France at Cantor Fitzgerald
11/10/2016	Cantor Fitzgerald	Set Price Target	Hold	$75.00	N/A	i Rating by Joseph France at Cantor Fitzgerald
9/14/2016	Stephens	Initiated Coverage	Overweight	$84.00	N/A	i
9/9/2016	Cantor Fitzgerald	Reiterated Rating	Hold		N/A	i Rating by Joseph France at Cantor Fitzgerald
9/4/2016	Wells Fargo & Company	Reiterated Rating	Hold		N/A	i
8/18/2016	Cantor Fitzgerald	Reiterated Rating	Hold		N/A	i Rating by Joseph France at Cantor Fitzgerald
8/8/2016	Mizuho	Boost Price Target	Neutral	$66.00 ➝ $77.00	N/A	i
6/23/2016	Cantor Fitzgerald	Initiated Coverage	Hold	$70.00	N/A	i Rating by Sharon Stein at Cantor Fitzgerald
6/4/2016	JMP Securities	Reiterated Rating	Hold		N/A	i Rating by David Turkaly at JMP Securities
3/31/2016	JMP Securities	Reiterated Rating	Hold		N/A	i Rating by Peter Martin at JMP Securities
3/30/2016	BMO Capital Markets	Boost Price Target	Outperform	$65.00 ➝ $69.00	N/A	i
3/11/2016	Bank of America	Upgrade	Underperform ➝ Neutral	$59.00 ➝ $67.00	N/A	i

(Data available from 1/20/2016 forward)

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Today's Range

Now: $66.54

$65.68

$67.12

50 Day Range

MA: $67.95

$65.46

$71.04

52 Week Range

Now: $66.54

$31.37

$91.12

Volume

214,731 shs

Average Volume

301,344 shs

Market Capitalization

$2.98 billion

P/E Ratio

15.62

Dividend Yield

6.72%

Beta

0.88

Frequently Asked Questions

What sell-side analysts currently cover shares of National Health Investors?

The following sell-side analysts have issued stock ratings on National Health Investors in the last twelve months: Berenberg Bank, BMO Capital Markets, JMP Securities, KeyCorp, Mizuho, Stifel Nicolaus, SunTrust Banks, Inc., TheStreet, Wells Fargo & Company, and Zacks Investment Research.

What is the current price target for National Health Investors?

7 Wall Street analysts have set twelve-month price targets for National Health Investors in the last year. Their average twelve-month price target is $64.29, suggesting a possible downside of 3.6%. Berenberg Bank has the highest price target set, predicting NHI will reach $94.00 in the next twelve months. KeyCorp has the lowest price target set, forecasting a price of $40.00 for National Health Investors in the next year.

What is the current consensus analyst rating for National Health Investors?

National Health Investors currently has 2 sell ratings and 6 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NHI, but not buy more shares or sell existing shares.

What other companies compete with National Health Investors?

Other companies that are similar to National Health Investors include American Tower, Public Storage, Welltower, Weyerhaeuser, Ventas, Extra Space Storage, HCP, Medical Properties Trust, Omega Healthcare Investors, CubeSmart, Life Storage, Rayonier, Healthcare Realty Trust, Ryman Hospitality Properties and Sabra Health Care REIT.

How do I contact National Health Investors' investor relations team?

National Health Investors' physical mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust's listed phone number is 615-890-9100 and its investor relations email address is investorrelations@nhireit.com. The official website for National Health Investors is www.nhireit.com.

NYSE:NHI - National Health Investors Stock Price Target and Predictions

Analyst Price Target for NHI

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of National Health Investors?

What is the current price target for National Health Investors?

What is the current consensus analyst rating for National Health Investors?

What other companies compete with National Health Investors?

How do I contact National Health Investors' investor relations team?